Promis Neurosciences (PMN) vs Seer, Inc. (SEER)
Promis Neurosciences and Seer, Inc. are both Biotechnology companies. Promis Neurosciences and Seer, Inc. are of similar size ($103.8M and $103.6M). Promis Neurosciences grew revenue faster over the last twelve months: 450.0% against −12.7%. Promis Neurosciences has the higher net margin (0.00% vs −478.1%) and the higher return on invested capital (0.00% vs −60.8%). Across the 16 metrics below, Seer, Inc. leads on 9 and Promis Neurosciences on 7.
Valuation
Profitability
| Metric | PMN | SEER | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 47.70% | 65.16% |
| Operating margin | 0.00% | (498.19%) | 0.00% |
| Net margin | 0.00% | (478.05%) | 0.00% |
| Free cash flow margin | 0.00% | (309.34%) | 0.00% |
| Return on equity | (172.30%) | (26.45%) | (57.72%) |
| Return on assets | (127.57%) | (23.47%) | (49.22%) |
| Return on invested capital | 0.00% | (60.78%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack